Jbm (Healthcare) Ltd
HKEX:2161
Jbm (Healthcare) Ltd
Cash from Operating Activities
Jbm (Healthcare) Ltd
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Jbm (Healthcare) Ltd
HKEX:2161
|
Cash from Operating Activities
HK$145.6m
|
CAGR 3-Years
56%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
U
|
United Laboratories International Holdings Ltd
HKEX:3933
|
Cash from Operating Activities
¥2.6B
|
CAGR 3-Years
18%
|
CAGR 5-Years
16%
|
CAGR 10-Years
8%
|
S
|
Sino Biopharmaceutical Ltd
HKEX:1177
|
Cash from Operating Activities
¥5B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
0%
|
CAGR 10-Years
15%
|
C
|
China Traditional Chinese Medicine Holdings Co Ltd
HKEX:570
|
Cash from Operating Activities
¥221.7m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
10%
|
C
|
China Resources Pharmaceutical Group Ltd
HKEX:3320
|
Cash from Operating Activities
HK$10.7B
|
CAGR 3-Years
12%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
HUTCHMED (China) Ltd
LSE:HCM
|
Cash from Operating Activities
$219.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
46%
|
See Also
What is Jbm (Healthcare) Ltd's Cash from Operating Activities?
Cash from Operating Activities
145.6m
HKD
Based on the financial report for Mar 31, 2023, Jbm (Healthcare) Ltd's Cash from Operating Activities amounts to 145.6m HKD.
What is Jbm (Healthcare) Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
12%
Over the last year, the Cash from Operating Activities growth was 143%. The average annual Cash from Operating Activities growth rates for Jbm (Healthcare) Ltd have been 56% over the past three years , 12% over the past five years .